ArticleEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie2026
Efficacy of PRP versus hyaluronic acid in obese individuals with knee osteoarthritis: a retrospective study.
Article in European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Re: efficacy of platelet-rich plasma versus hyaluronic acid in obese individuals with knee osteoarthritis.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionObesity is a common comorbidity in patients with knee osteoarthritis (KOA). Both viscosupplementation and platelet-rich plasma (PRP) intra-articular injections may alleviate KOA symptoms. To better guide patient selection for PRP therapy, we compared the outcomes of these treatments in obese individuals. MATERIALS AND
methodsThis retrospective study included 99 obese patients who received intra-articular injections of either PRP (n = 43) or hyaluronic acid (HA, n = 56) between January 2014 and October 2017. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), visual analogue scale (VAS), and range of motion (ROM) were assessed before the injection and at 15 days, 6 months, 12 months, and the final follow-up. Outcomes were then compared between the two treatment groups.
resultsObese patients treated with HA had a higher rate of arthroplasty (35.7% vs. 9.3%, p = 0.002), reduced ROM, poorer VAS and WOMAC scores, and a higher overall risk of arthroplasty (log-rank p = 0.177) compared with those treated with PRP. Cox proportional hazards analysis indicated a non-significant trend toward a reduced risk of knee arthroplasty in the PRP group (HR = 0.46, 95% CI 0.15-1.42, p = 0.176) over average follow-up of 16.5 month for all patients.
conclusionsIntra-articular PRP injections were associated with better outcomes than HA in obese patients with KOA. PRP may delay the need for arthroplasty and could serve as a valuable therapeutic option for selected patients who do not respond to conventional treatments. Due to several limitations, further large-scale studies are warranted to confirm the effectiveness of this promising approach in this high-risk population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.